Holen Sie sich die Stockscreener-App
13.68
0.96%
0.18
Schlusskurs vom Vortag:
$13.50
Offen:
$13.71
24-Stunden-Volumen:
75,099
Relative Volume:
0.08
Marktkapitalisierung:
$637.59M
Einnahmen:
$128.29M
Nettoeinkommen (Verlust:
$-30.69M
KGV:
-16.68
EPS:
-0.82
Netto-Cashflow:
$-27.17M
1W Leistung:
-8.58%
1M Leistung:
-3.95%
6M Leistung:
-63.36%
1J Leistung:
-76.12%
1-Tages-Spanne:
$13.51
$13.81
1-Wochen-Bereich:
$13.41
$14.88
52-Wochen-Spanne:
$12.53
$60.81
Rxsight Inc Stock (RXST) Company Profile
Firmenname
Rxsight Inc
Sektor
Branche
Telefon
949-521-7822
Adresse
100 COLUMBIA STREET, ALISO VIEJO
Vergleichen Sie RXST mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RXST
Rxsight Inc
|
13.66 | 637.59M | 128.29M | -30.69M | -27.17M | -0.82 |
|
ABT
Abbott Laboratories
|
131.97 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
|
SYK
Stryker Corp
|
372.60 | 147.15B | 23.22B | 2.86B | 3.58B | 7.40 |
|
BSX
Boston Scientific Corp
|
101.16 | 146.97B | 17.55B | 2.03B | 2.72B | 1.37 |
|
MDT
Medtronic Plc
|
85.77 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
73.17 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Rxsight Inc Stock (RXST) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-19 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-04-15 | Eingeleitet | Piper Sandler | Neutral |
| 2025-04-09 | Herabstufung | UBS | Buy → Neutral |
| 2025-04-04 | Herabstufung | JP Morgan | Overweight → Underweight |
| 2025-04-03 | Herabstufung | BofA Securities | Buy → Underperform |
| 2024-12-20 | Herabstufung | Stifel | Buy → Hold |
| 2024-12-11 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-12-06 | Eingeleitet | UBS | Buy |
| 2024-10-29 | Eingeleitet | Jefferies | Buy |
| 2024-08-20 | Bestätigt | Needham | Buy |
| 2024-08-06 | Bestätigt | Needham | Buy |
| 2024-05-07 | Bestätigt | BTIG Research | Buy |
| 2023-12-13 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-12-12 | Eingeleitet | Stifel | Buy |
| 2023-12-04 | Eingeleitet | Morgan Stanley | Overweight |
| 2023-04-13 | Eingeleitet | Oppenheimer | Outperform |
| 2022-12-12 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-08 | Eingeleitet | Needham | Buy |
Alle ansehen
Rxsight Inc Aktie (RXST) Neueste Nachrichten
Market Insight: RxSight Inc (RXST)’s Notable Drop, Closing at 13.50 - DWinneX
The Price Is Right For RxSight, Inc. (NASDAQ:RXST) - simplywall.st
When (RXST) Moves Investors should Listen - news.stocktradersdaily.com
RxSight, Inc. (NASDAQ:RXST) Given Consensus Rating of “Hold” by Analysts - Defense World
Wells Fargo Upgrades RxSight (RXST), Sees LAL Technology as Undervalued - MSN
RxSight Stock: Valuation Blowout Creates Opportunity (NASDAQ:RXST) - Seeking Alpha
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires 16,140 Shares of RxSight, Inc. (NASDAQ:RXST) - Defense World
RxSight Inc (RXST) Stock Price Down 3.04% on Jun 4 - GuruFocus
Where are the Opportunities in (RXST) - news.stocktradersdaily.com
RxSight Inc (RXST) Shares Down 7.27% on May 30 - GuruFocus
Midday Stock Roundup: Tilly’s Up 14% Ahead of Q1 Results - Orange County Business Journal
RxSight, Inc. (NASDAQ:RXST) Shares Sold by Nuveen Asset Management LLC - Defense World
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Grows Position in RxSight, Inc. (NASDAQ:RXST) - Defense World
RxSight at Stifel Forum: Navigating Market Challenges By Investing.com - Investing.com Canada
RxSight, Inc. (NASDAQ:RXST) Shares Sold by D. E. Shaw & Co. Inc. - Defense World
RxSight (NASDAQ:RXST) Stock Price Down 4.7% – Here’s Why - Defense World
(RXST) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
Do Options Traders Know Something About RxSight Stock We Don't? - TradingView
RxSight, Inc. (NASDAQ:RXST) Given Consensus Recommendation of “Hold” by Brokerages - Defense World
RxSight, Inc. to Participate in the Stifel 2025 Virtual Ophthalmology Forum - GlobeNewswire
RxSight (NASDAQ:RXST) Upgraded to Overweight at Wells Fargo & Company - Defense World
RxSight Inc (RXST) Stock Price Up 13.14% on May 19 - GuruFocus
Sector Update: Health Care - marketscreener.com
RxSight Shares Rise After Upgrade From Wells Fargo - marketscreener.com
Wells Fargo lifts RxSight stock rating, raises target to $25 By Investing.com - Investing.com Canada
RXST Sees Rating Upgrade and Price Target Increase by Wells Farg - GuruFocus
Deep Dive Into RxSight Stock: Analyst Perspectives (13 Ratings) - Benzinga
Wells Fargo Upgrades RxSight (RXST) - Nasdaq
Wells Fargo Upgrades RxSight to Overweight From Equalweight, Lifts Price Target to $25 From $17 - marketscreener.com
Wells Fargo lifts RxSight stock rating, raises target to $25 - Investing.com Australia
Wells Fargo Upgrades RxSight (RXST) with Increased Price Target | RXST Stock News - GuruFocus
RxSight (RXST) Receives Upgrade from Wells Fargo with Increased Price Target | RXST Stock News - GuruFocus
Wells Fargo upgrades RxSight on ‘strong first-mover advantage’ - TipRanks
RxSight Inc (RXST) Stock Price Up 5.15% on May 16 - GuruFocus
Northern Trust Corp Raises Stock Holdings in RxSight, Inc. (NASDAQ:RXST) - Defense World
Rxsight at Bank of America Conference: Strategic Shifts Amid Challenges By Investing.com - Investing.com Nigeria
Transcript : RxSight, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-14-2025 03 - marketscreener.com
Rxsight at Bank of America Conference: Strategic Shifts Amid Challenges - Investing.com Australia
Price T Rowe Associates Inc. MD Sells 23,863 Shares of RxSight, Inc. (NASDAQ:RXST) - Defense World
Morgan Stanley Adjusts Price Target on RxSight to $20 From $42, Maintains Overweight Rating - marketscreener.com
RxSight, Inc. (NASDAQ:RXST) Just Reported Earnings, And Analysts Cut Their Target Price - Yahoo Finance
Dimensional Fund Advisors LP Acquires 237,877 Shares of RxSight, Inc. (NASDAQ:RXST) - Defense World
Insiders Who Purchased US$1.42m Of RxSight Stock May Not Have Expected 12% Tumble - simplywall.st
Top 3 Health Care Stocks That Are Preparing To Pump This Quarter - Benzinga
RxSight: Favorable Risk/Reward Scenario with Strong Growth Prospects and Attractive Valuation - TipRanks
RxSight (NASDAQ:RXST) Sets New 12-Month Low After Earnings Miss - Defense World
Finanzdaten der Rxsight Inc-Aktie (RXST)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.01%
0.24%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):